158 related articles for article (PubMed ID: 35890163)
1. Molecular docking and virtual screening for novel protein tyrosine phosphatase 1B (PTP1B) inhibitors.
Rao PS; Muvva C; Geethanjali K; Bastipati SB; Kalashikam R
Bioinformation; 2012; 8(17):834-7. PubMed ID: 23139594
[TBL] [Abstract][Full Text] [Related]
2. Structure based design of compounds from natural sources for diabetes and inflammation.
Suhitha S; Gunasekaran K; Velmurugan D
Bioinformation; 2012; 8(23):1125-31. PubMed ID: 23275708
[TBL] [Abstract][Full Text] [Related]
3. Anti-Obesity Therapeutic Targets Studied In Silico and In Vivo: A Systematic Review.
de Medeiros WF; Gomes AFT; Aguiar AJFC; de Queiroz JLC; Bezerra IWL; da Silva-Maia JK; Piuvezam G; Morais AHA
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731918
[TBL] [Abstract][Full Text] [Related]
4. Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents.
Su J; Luo Y; Hu S; Tang L; Ouyang S
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686185
[TBL] [Abstract][Full Text] [Related]
5. Anti-Diabetic Activity of Glycyrrhetinic Acid Derivatives FC-114 and FC-122: Scale-Up, In Silico, In Vitro, and In Vivo Studies.
Álvarez-Almazán S; Solís-Domínguez LC; Duperou-Luna P; Fuerte-Gómez T; González-Andrade M; Aranda-Barradas ME; Palacios-Espinosa JF; Pérez-Villanueva J; Matadamas-Martínez F; Miranda-Castro SP; Mercado-Márquez C; Cortés-Benítez F
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628991
[TBL] [Abstract][Full Text] [Related]
6. The importance of including the C-terminal domain of PTP1B
Coronell-Tovar A; Cortés-Benítez F; González-Andrade M
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2170369. PubMed ID: 36997321
[TBL] [Abstract][Full Text] [Related]
7. Dual PTP1B/TC-PTP Inhibitors: Biological Evaluation of 3-(Hydroxymethyl)cinnoline-4(
Derkach KV; Gureev MA; Babushkina AA; Mikhaylov VN; Zakharova IO; Bakhtyukov AA; Sorokoumov VN; Novikov AS; Krasavin M; Shpakov AO; Balova IA
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901928
[TBL] [Abstract][Full Text] [Related]
8. Myocardial protection of S-nitroso-L-cysteine in diabetic cardiomyopathy mice.
Peng L; Zhu M; Huo S; Shi W; Jiang T; Peng D; Wang M; Jiang Y; Guo J; Men L; Huang B; Wang Q; Lv J; Lin L; Li S
Front Endocrinol (Lausanne); 2022; 13():1011383. PubMed ID: 36313766
[TBL] [Abstract][Full Text] [Related]
9. Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders.
Singh S; Singh Grewal A; Grover R; Sharma N; Chopra B; Kumar Dhingra A; Arora S; Redhu S; Lather V
Bioorg Chem; 2022 Apr; 121():105626. PubMed ID: 35255350
[TBL] [Abstract][Full Text] [Related]
10. The design strategy of selective PTP1B inhibitors over TCPTP.
Li X; Wang L; Shi D
Bioorg Med Chem; 2016 Aug; 24(16):3343-52. PubMed ID: 27353889
[TBL] [Abstract][Full Text] [Related]
11. Computational Methods in Cooperation with Experimental Approaches to Design Protein Tyrosine Phosphatase 1B Inhibitors in Type 2 Diabetes Drug Design: A Review of the Achievements of This Century.
Campos-Almazán MI; Hernández-Campos A; Castillo R; Sierra-Campos E; Valdez-Solana M; Avitia-Domínguez C; Téllez-Valencia A
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890163
[TBL] [Abstract][Full Text] [Related]
12. The discovery of a novel and selective inhibitor of PTP1B over TCPTP: 3D QSAR pharmacophore modeling, virtual screening, synthesis, and biological evaluation.
Ma Y; Jin YY; Wang YL; Wang RL; Lu XH; Kong DX; Xu WR
Chem Biol Drug Des; 2014 Jun; 83(6):697-709. PubMed ID: 24418013
[TBL] [Abstract][Full Text] [Related]
13. Pyrazoles as novel protein tyrosine phosphatase 1B (PTP1B) inhibitors: An in vitro and in silico study.
Rocha S; Lucas M; Silva VLM; Gomes PMO; Silva AMS; Araújo AN; Aniceto N; Guedes RC; Corvo ML; Fernandes E; Freitas M
Int J Biol Macromol; 2021 Jun; 181():1171-1182. PubMed ID: 33857515
[TBL] [Abstract][Full Text] [Related]
14. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel and selective inhibitors targeting protein tyrosine phosphatase 1B (PTP1B): Virtual screening and molecular dynamic simulation.
Akyol K; Kilic D
Comput Biol Med; 2021 Dec; 139():104959. PubMed ID: 34735946
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
